1 Profile of Independent Clinical Laboratory
1.1 Definition
1.2 Industry Chain
2 Overview of China Independent Clinical Laboratory Industry
2.1 Policies
2.1.1 Access Policies
2.1.2 Industry Policies
2.2 Global Market
2.2.1 Status Quo
2.2.2 Model Enterprises
2.3 Current Development
2.4 Competitive Landscape
2.5 Dynamics and Prospects
3 Upstream and Downstream Industry of China Independent Clinical Laboratory
3.1 Upstream Sector
3.1.1 Status Quo
3.1.2 Product Mix
3.2 Downstream Sector
3.2.1 Huge Market Scale of Chinese Independent Clinical Laboratory
3.2.2 Medical Reform Encourages Rapid Development of Independent Clinical Laboratory in China
3.2.3 Diversified Demand Promotes the Upgrading of Independent Clinical Laboratory Industry in China
4 Key Players in China
4.1 Kingmed Diagnostics Co., Ltd
4.1.1 Profile
4.1.2 Operation and Prospects
4.2 Zhejiang D.A. Diagnostics Co., Ltd
4.2.1 Profile
4.2.2 Operation
4.2.3 Revenue Structure
4.2.4 Gross Margin
4.2.5 Clients and Suppliers
4.2.6 R & D and Investment
4.2.7 Independent Clinical Laboratory Service
4.3 DAAN Gene Co., Ltd
4.3.1 Profile
4.3.2 Operation
4.3.3 Revenue Structure
4.3.5 Gross Margin
4.3.6 Independent Clinical Laboratory Service
4.4 Beijing NYMPHAVN Biotechnology Corporation Ltd
4.4.1 Profile
4.4.2 Operation
4.4.3 Revenue Structure
4.4.4 Gross Margin
4.4.5 Clients and Suppliers
4.4.6 R & D and Investment
4.5 ADICON Clinical Laboratories, Inc
4.5 Beijing Deyi Biotechnology Medical Co., Ltd
4.6 Beijing Adinovo Genetic Technology Co., Ltd
4.7 Zhiyuan Medical Inspection Institute Co., Ltd
4.8 Kindstar Global (Beijing) Medical Technology Co., Ltd
報告圖表目錄Industry Chain of Independent Clinical Laboratory
Comparison of Independent Clinical Laboratory between China and the USA by Undertaker
Policies Concerning Independent Clinical Laboratory Industry in China, 2010-2011
Market Share of Independent Clinical Laboratory Industry in the U.S. by Diagnostic Item, 2003-2010
Market Share of Medical Diagnostics in the USA by Undertaker, 2010
Revenue and Profit of Quest Diagnostics, 2007-2011
Revenue Structure of Quest Diagnostics by Business, 2011
Major M&As of Quest Diagnostics, 2006-2011
Revenue and Profit of Labcorp, 2007-2011
Revenue Breakdown of Labcorp by Business, 2009-2011
Major M&As of Labcorp, 2007-2011
Top 5 Diagnostic Items of Massachusetts General Hospital and Domestic Third-grade Class-A Hospital
Characteristics and Market Share of Major Independent Clinical Laboratories in China, by the End of 2011
Market Size and Growth Rate of In Vitro Diagnostic Industry in China, 2007-2014E
Market Scale and Growth Rate of In Vitro Diagnostic Reagent in China, 2007-2014E
Structure of In Vitro Diagnostic Reagent in China, 2011
Business Revenue and Diagnostics Revenue of Medical Institutions in China, 2010
Number of Visits in Hospitals and Basic Medical Institutions, 2008-2011
Number of Public and Non-public Hospitals in China, 2008-2011
Layout of D.A. Diagnostics’ Independent Clinical Laboratory
Revenue and Profit of D.A. Diagnostics, 2008-2012
Revenue Breakdown of D.A. Diagnostics by Business, 2008-2011
Revenue Structure of D.A. Diagnostics by Business, 2008-2011
Revenue Breakdown of D.A. Diagnostics by Region, 2008-2011
Revenue Structure of D.A. Diagnostics by Region, 2008-2011
Gross Margin of D.A. Diagnostics by Business, 2008-2011
D.A. Diagnostics’ Revenue from Top 5 Clients and % of Total Revenue, 2008-2011
Name List and Revenue Contribution of D.A. Diagnostics’ Top 5 Clients, 2009-2011
D.A. Diagnostics’ Procurement from Top 5 Suppliers and % of Total Procurement, 2008-2011
Name List and Procurement Contribution of D.A. Diagnostics’ Top 5 Suppliers, 2009-2011
R&D Costs and % of Total Revenue of D.A. Diagnostics, 2008-2011
Revenue and Gross Margin of D.A. Diagnostics’ Independent Diagnostics Business, 2008-2011
Revenue and Gross Margin of D.A. Diagnostics’ Independent Diagnostics Business by Product, 2008-2011
Revenue Structure of D.A. Diagnostics’ Independent Diagnostics Business by Client, 2010-2011
Forecast of D.A. Diagnostics’ Revenue by Business, 2011-2014E
Revenue and Profit of DAAN Gene, 2008-2012
Revenue Breakdown of DAAN Gene by Product, 2008-2011
Revenue Structure of DAAN Gene by Region, 2008-2011
Gross Margin of DAAN Gene by Product, 2008-2011
Revenue and Gross Margin Of DAAN Gene’s Independent Diagnostics Business, 2008-2011
Net Assets, Revenue and Net Income of DAAN Gene’s Subsidiaries Engaging in Independent Diagnostics Business, 2011
Revenue and Profit of NYMPHAVN Biotechnology, 2009-2011
Revenue Breakdown of NYMPHAVN Biotechnology by Product, 2009-2011
Revenue Structure of NYMPHAVN Biotechnology by Product, 2009-2011
Revenue Breakdown of NYMPHAVN Biotechnology by Region, 2010-2011
Gross Margin of NYMPHAVN Biotechnology by Product, 2009-2011
NYMPHAVN Biotechnology’s Revenue from Top 5 Clients and % of Total Revenue, 2009-2011
Name List and Revenue Contribution of NYMPHAVN Biotechnology’s Top 5 Clients, 2009-2011
NYMPHAVN Biotechnology’s Procurement from Top 5 Suppliers and % of Total Procurement, 2009-2011
Name List and Procurement Contribution of NYMPHAVN Biotechnology’s Top 5 Suppliers, 2009-2011
R&D Costs and % of Total Revenue of NYMPHAVN Biotechnology, 2009-2011
Distribution and Established Date of Adicon’s Independent Clinical Laboratory